Clinical Trials
16
Active:0
Completed:12
Trial Phases
3 Phases
Early Phase 1:1
Phase 1:4
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (44.4%)Phase 1
4 (44.4%)Early Phase 1
1 (11.1%)Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea
Not yet recruiting
- Conditions
- DyspneaHeart Failure Acute
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 650
- Registration Number
- NCT07147699
External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Recruiting
- Conditions
- Upper Gastrointestinal Bleeding (UGIB)Glasgow-Blatchford Score
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 250
- Registration Number
- NCT07089277
- Locations
- 🇹🇳
Sahloul University Hospital, Sousse, Tunisia
Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities
Completed
- Conditions
- Sepsis
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 325
- Registration Number
- NCT06953154
- Locations
- 🇹🇳
Sahloul University Hospital, Sousse, Tunisia
Clinical-biological Score for Upper Gastrointestinal Bleeding
Completed
- Conditions
- Gastro Intestinal Bleeding
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 150
- Registration Number
- NCT05688501
- Locations
- 🇹🇳
HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness
Phase 1
Completed
- Conditions
- Influenza -Like Illness
- Interventions
- Drug: kelavit
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 150
- Registration Number
- NCT05670444
- Locations
- 🇹🇳
CHU sahloul, Sousse, Tunisia
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found